170 related articles for article (PubMed ID: 15578448)
1. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV).
Thiele J; Kvasnicka HM
Histol Histopathol; 2005 Jan; 20(1):317-28. PubMed ID: 15578448
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of polycythemia vera based on bone marrow pathology.
Thiele JM; Kvasnicka HM
Curr Hematol Rep; 2005 May; 4(3):218-23. PubMed ID: 15865875
[TBL] [Abstract][Full Text] [Related]
3. Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?
Thiele J; Kvasnicka HM
Curr Hematol Malig Rep; 2006 Jun; 1(2):87-92. PubMed ID: 20425337
[TBL] [Abstract][Full Text] [Related]
4. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
Michiels JJ
Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
[TBL] [Abstract][Full Text] [Related]
7. Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients.
Thiele J; Kvasnicka HM; Muehlhausen K; Walter S; Zankovich R; Diehl V
Pathol Res Pract; 2001; 197(2):77-84. PubMed ID: 11261821
[TBL] [Abstract][Full Text] [Related]
8. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
9. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
Michiels JJ; Thiele J
Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow features of diagnostic impact in erythrocytosis.
Thiele J; Kvasnicka HM; Diehl V
Ann Hematol; 2005 Jun; 84(6):362-7. PubMed ID: 15803315
[TBL] [Abstract][Full Text] [Related]
12. [ Polyglobuly versus polycythemia vera].
Thiele J; Kvasnicka HM
Pathologe; 2000 Jan; 21(1):24-30. PubMed ID: 10663666
[TBL] [Abstract][Full Text] [Related]
13. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
[TBL] [Abstract][Full Text] [Related]
14. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
15. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
Mossuz P; Girodon F; Donnard M; Latger-Cannard V; Dobo I; Boiret N; Lecron JC; Binquet C; Barro C; Hermouet S; Praloran V
Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203
[TBL] [Abstract][Full Text] [Related]
17. Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies.
Thiele J; Zankovich R; Schneider G; Kremer B; Fischer R; Diehl V
Anal Quant Cytol Histol; 1988 Oct; 10(5):375-82. PubMed ID: 3207462
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow findings in blast phase of polycythemia vera.
Hidalgo López JE; Carballo-Zarate A; Verstovsek S; Wang SA; Hu S; Li S; Xu J; Zuo W; Tang Z; Yin CC; Medeiros LJ; Bueso-Ramos CE; Tang G
Ann Hematol; 2018 Mar; 97(3):425-434. PubMed ID: 29285580
[TBL] [Abstract][Full Text] [Related]
20. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.
Barbui T; Thiele J; Vannucchi AM; Tefferi A
Blood Cancer J; 2015 Aug; 5(8):e337. PubMed ID: 26832847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
